{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:42:23Z","timestamp":1763037743476,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades infecciosas y microbiologia clinica (English ed.)"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.eimce.2022.03.001","type":"journal-article","created":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T08:54:15Z","timestamp":1651049655000},"page":"296-301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Experience in the use of dalbavancin in diabetic foot infection"],"prefix":"10.1016","volume":"40","author":[{"given":"Gema","family":"Navarro-Jim\u00e9nez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Fuentes-Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonor","family":"Moreno-N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Alfayate-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Campelo-Gutierrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sira","family":"Sanz-M\u00e1rquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elia","family":"P\u00e9rez-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Velasco-Arribas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Herv\u00e1s-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oriol","family":"Mart\u00edn-Segarra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Emilio","family":"Losa-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2 Suppl","key":"10.1016\/j.eimce.2022.03.001_bib0005","first-page":"26","article-title":"Diabetic foot infections: a comprehensive overview","volume":"23","author":"Pitocco","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.eimce.2022.03.001_bib0010","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1464-5491.2010.03192.x","article-title":"Differences in minor amputation rate in diabetic foot disease throughout Europe are in part explained by differences in disease severity at presentation","volume":"28","author":"Van Battum","year":"2011","journal-title":"Diabet Med"},{"key":"10.1016\/j.eimce.2022.03.001_bib0015","first-page":"1929","article-title":"Diabetic foot ulcer\u2014a review on pathophysiology, classification and microbial etiology","volume":"9","author":"Saba","year":"2015","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.eimce.2022.03.001_bib0020","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1093\/cid\/cis346","article-title":"Infectious Diseases Society of America. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections","volume":"54","author":"Lipsky","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimce.2022.03.001_bib0025","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1310480","article-title":"Once-weekly dalbavancin versus daily conventional therapy for skin infection","volume":"370","author":"Boucher","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimce.2022.03.001_bib0030","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02280-18","article-title":"Safety and efficacy of prolonged use of dalbavancin in bone and joint infections","volume":"63","author":"Morata","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimce.2022.03.001_bib0035","doi-asserted-by":"crossref","first-page":"ofy331","DOI":"10.1093\/ofid\/ofy331","article-title":"Dalbavancin for the treatment of osteomyelitis in adult patients: a randomized clinical trial of efficacy and safety","volume":"6","author":"Rappo","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.eimce.2022.03.001_bib0040","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s15010-019-01354-x","article-title":"Real-world experience with dalbavancin therapy in gram-positive skin and soft tissue infection, bone and joint infection","volume":"47","author":"Tobudic","year":"2019","journal-title":"Infection"},{"key":"10.1016\/j.eimce.2022.03.001_bib0045","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/jama.1995.03520330051036","article-title":"Probing to bone in infected pedal ulcers. A clinical sign of underlying osteomyelitis in diabetic patients","volume":"273","author":"Grayson","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.eimce.2022.03.001_bib0050","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/cid\/ciw445","article-title":"Diagnostic accuracy of probe to bone to detect osteomyelitis in the diabetic foot: a systematic review","volume":"63","author":"Lam","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimce.2022.03.001_bib0055","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1464-5491.2010.03150.x","article-title":"Diagnosing diabetic foot osteomyelitis: is the combination of probe-to-bone test and plain radiography sufficient for high-risk inpatients?","volume":"28","author":"Arag\u00f3n-S\u00e1nchez","year":"2011","journal-title":"Diabet Med"},{"issue":"Suppl 1","key":"10.1016\/j.eimce.2022.03.001_bib0060","doi-asserted-by":"crossref","first-page":"e3280","DOI":"10.1002\/dmrr.3280","article-title":"Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update)","volume":"36","author":"Lipsky","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.eimce.2022.03.001_bib0065","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","article-title":"Validation of a combined comorbidity index","volume":"47","author":"Charlson","year":"1994","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.eimce.2022.03.001_bib0070","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/1757177415617245","article-title":"The reliability of the McCabe score as a marker of co-morbidity in healthcare-associated infection point prevalence studies","volume":"17","author":"Reilly","year":"2016","journal-title":"J Infect Prev"},{"key":"10.1016\/j.eimce.2022.03.001_bib0075","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jclinepi.2012.02.018","article-title":"Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes","volume":"65","author":"Gnjidic","year":"2012","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.eimce.2022.03.001_bib0080","unstructured":"Ministerio de Sanidad, Servicios Sociales e Igualdad. Lista de medicamentosde alto riesgo en pacientes cr\u00f3nicos [Accessed 23 June 2020]. Available from: http:\/\/www.ismp-espana.org\/ficheros\/Relaci\u00f3n%20medicamentos%20alto%20riesgo%20en%20cronicos.pdf."},{"author":"Asociaci\u00f3n m\u00e9dica mundial","key":"10.1016\/j.eimce.2022.03.001_bib0085"},{"key":"10.1016\/j.eimce.2022.03.001_bib0090","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/clpt.2008.224","article-title":"The effects of polypharmacy in older adults","volume":"85","author":"Hilmer","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.eimce.2022.03.001_bib0095","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1128\/AAC.02626-15","article-title":"Relationship between adherence to oral antibiotics and postdischarge clinical outcomes among patients hospitalized with staphylococcus aureus skin infections","volume":"60","author":"Eells","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimce.2022.03.001_bib0100","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1128\/AAC.04550-14","article-title":"Extended-duration dosing and distribution of dalbavancin into bone and articular tissue","volume":"59","author":"Dunne","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimce.2022.03.001_bib0105","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/jac\/dkh513","article-title":"A review of the microbiology, antibiotic usage and resistance in chronic skin wounds","volume":"55","author":"Howell-Jones","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimce.2022.03.001_bib0110","first-page":"317","article-title":"Diabetic foot infections. Prevalence and antibiotic sensitivity of the causative microorganisms","volume":"27","author":"Martinez-Gomez Dde","year":"2009","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimce.2022.03.001_bib0115","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.diagmicrobio.2005.08.005","article-title":"Emergence of multidrug-resistant Corynebacterium striatum as a nosocomial pathogen in long-term hospitalized patients with underlying diseases","volume":"54","author":"Otsuka","year":"2006","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.eimce.2022.03.001_bib0120","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1469-0691.1997.tb00470.x","article-title":"Clinical significance of Corynebacterium striatum isolated from human samples","volume":"3","author":"Martinez-Martinez","year":"1997","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimce.2022.03.001_bib0125","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2147\/IDR.S184518","article-title":"Molecular epidemiology and clinical significance of Corynebacterium striatum isolated from clinical specimens","volume":"12","author":"Suh","year":"2019","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.eimce.2022.03.001_bib0130","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.diagmicrobio.2012.11.024","article-title":"Update of dalbavancin spectrum and potency in the USA: report from the SENTRY Antimicrobial Surveillance Program (2011)","volume":"75","author":"Jones","year":"2013","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["Enfermedades infecciosas y microbiologia clinica (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2529993X22000405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2529993X22000405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:01:35Z","timestamp":1762866095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2529993X22000405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S2529993X22000405"],"URL":"https:\/\/doi.org\/10.1016\/j.eimce.2022.03.001","relation":{},"ISSN":["2529-993X"],"issn-type":[{"type":"print","value":"2529-993X"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Experience in the use of dalbavancin in diabetic foot infection","name":"articletitle","label":"Article Title"},{"value":"Enfermedades infecciosas y microbiologia clinica (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimce.2022.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.eimc.2020.11.013","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}